Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2005 1
2007 1
2009 1
2011 3
2012 1
2013 3
2014 6
2015 5
2016 5
2017 5
2018 17
2019 18
2020 17
2021 18
2022 28
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Results by year
Filters applied: . Clear all
Page 1
Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, Gronseth GS, Marson D, Pringsheim T, Day GS, Sager M, Stevens J, Rae-Grant A. Petersen RC, et al. Among authors: day gs. Neurology. 2018 Jan 16;90(3):126-135. doi: 10.1212/WNL.0000000000004826. Epub 2017 Dec 27. Neurology. 2018. PMID: 29282327 Free PMC article.
Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.
Pringsheim T, Day GS, Smith DB, Rae-Grant A, Licking N, Armstrong MJ, de Bie RMA, Roze E, Miyasaki JM, Hauser RA, Espay AJ, Martello JP, Gurwell JA, Billinghurst L, Sullivan K, Fitts MS, Cothros N, Hall DA, Rafferty M, Hagerbrant L, Hastings T, O'Brien MD, Silsbee H, Gronseth G, Lang AE; Guideline Subcommittee of the AAN. Pringsheim T, et al. Among authors: day gs. Neurology. 2021 Nov 16;97(20):942-957. doi: 10.1212/WNL.0000000000012868. Neurology. 2021. PMID: 34782410 Free PMC article. Review.
Rapidly Progressive Dementia.
Day GS. Day GS. Continuum (Minneap Minn). 2022 Jun 1;28(3):901-936. doi: 10.1212/CON.0000000000001089. Continuum (Minneap Minn). 2022. PMID: 35678409 Review.
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T. Rae-Grant A, et al. Among authors: day gs. Neurology. 2018 Apr 24;90(17):777-788. doi: 10.1212/WNL.0000000000005347. Neurology. 2018. PMID: 29686116
Autoimmune Dementia.
Long JM, Day GS. Long JM, et al. Among authors: day gs. Semin Neurol. 2018 Jun;38(3):303-315. doi: 10.1055/s-0038-1660480. Epub 2018 Jul 16. Semin Neurol. 2018. PMID: 30011411 Review.
Reversible Dementias.
Day GS. Day GS. Continuum (Minneap Minn). 2019 Feb;25(1):234-253. doi: 10.1212/CON.0000000000000688. Continuum (Minneap Minn). 2019. PMID: 30707195 Review.
Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.
Fagan AM, Henson RL, Li Y, Boerwinkle AH, Xiong C, Bateman RJ, Goate A, Ances BM, Doran E, Christian BT, Lai F, Rosas HD, Schupf N, Krinsky-McHale S, Silverman W, Lee JH, Klunk WE, Handen BL, Allegri RF, Chhatwal JP, Day GS, Graff-Radford NR, Jucker M, Levin J, Martins RN, Masters CL, Mori H, Mummery CJ, Niimi Y, Ringman JM, Salloway S, Schofield PR, Shoji M, Lott IT; Alzheimer's Biomarker Consortium–Down Syndrome; Dominantly Inherited Alzheimer Network. Fagan AM, et al. Among authors: day gs. Lancet Neurol. 2021 Aug;20(8):615-626. doi: 10.1016/S1474-4422(21)00139-3. Lancet Neurol. 2021. PMID: 34302786 Free PMC article.
Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
Day GS, Yarbrough MY, Körtvelyessy P, Prüss H, Bucelli RC, Fritzler MJ, Mason W, Tang-Wai DF, Steriade C, Hébert J, Henson RL, Herries EM, Ladenson JH, Lopez-Chiriboga AS, Graff-Radford NR, Morris JC, Fagan A. Day GS, et al. Neurology. 2021 May 18;96(20):e2546-e2557. doi: 10.1212/WNL.0000000000011937. Epub 2021 Apr 1. Neurology. 2021. PMID: 33795390 Free PMC article.
The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology.
Apostolova LG, Aisen P, Eloyan A, Fagan A, Fargo KN, Foroud T, Gatsonis C, Grinberg LT, Jack CR Jr, Kramer J, Koeppe R, Kukull WA, Murray ME, Nudelman K, Rumbaugh M, Toga A, Vemuri P, Trullinger A, Iaccarino L, Day GS, Graff-Radford NR, Honig LS, Jones DT, Masdeu J, Mendez M, Musiek E, Onyike CU, Rogalski E, Salloway S, Wolk DA, Wingo TS, Carrillo MC, Dickerson BC, Rabinovici GD; LEADS Consortium. Apostolova LG, et al. Among authors: day gs. Alzheimers Dement. 2021 Dec;17(12):2043-2055. doi: 10.1002/alz.12350. Epub 2021 May 21. Alzheimers Dement. 2021. PMID: 34018654 Free PMC article.
Sleep Disturbances in Patients with Autoimmune Encephalitis.
Blattner MS, Day GS. Blattner MS, et al. Among authors: day gs. Curr Neurol Neurosci Rep. 2020 Jun 10;20(7):28. doi: 10.1007/s11910-020-01048-0. Curr Neurol Neurosci Rep. 2020. PMID: 32524504 Free PMC article. Review.
121 results